BioStem Technologies, Inc. (BSEM)

USD 16.5

(-2.94%)

EBITDA Summary of BioStem Technologies, Inc.

  • BioStem Technologies, Inc.'s latest annual EBITDA in 2023 was -7.55 Million USD , down -53.92% from previous year.
  • BioStem Technologies, Inc.'s latest quarterly EBITDA in 2024 Q2 was 8.87 Million USD , up 91.08% from previous quarter.
  • BioStem Technologies, Inc. reported an annual EBITDA of -6.52 Million USD in 2022, down -243.59% from previous year.
  • BioStem Technologies, Inc. reported an annual EBITDA of -601.99 Thousand USD in 2021, up 19.03% from previous year.
  • BioStem Technologies, Inc. reported a quarterly EBITDA of 8.87 Million USD for 2024 Q2, up 91.08% from previous quarter.
  • BioStem Technologies, Inc. reported a quarterly EBITDA of N/A for 2023 FY, down -70.16% from previous quarter.

Annual EBITDA Chart of BioStem Technologies, Inc. (2023 - 2010)

Historical Annual EBITDA of BioStem Technologies, Inc. (2023 - 2010)

Year EBITDA EBITDA Growth
2023 -7.55 Million USD -53.92%
2022 -6.52 Million USD -243.59%
2021 -601.99 Thousand USD 19.03%
2020 -1.59 Million USD 70.39%
2019 -5.38 Million USD 24.85%
2018 -7.27 Million USD -54.85%
2017 -4.59 Million USD -42.28%
2016 -3.25 Million USD -40.73%
2015 -2.3 Million USD -1065.83%
2014 -198.26 Thousand USD -231.75%
2013 -195.77 Thousand USD -295.08%
2012 -15.12 Thousand USD 94.48%
2011 -273.85 Thousand USD -65.21%
2010 -165.76 Thousand USD 0.0%

Peer EBITDA Comparison of BioStem Technologies, Inc.

Name EBITDA EBITDA Difference
Eiger BioPharmaceuticals, Inc. -71.03 Million USD 89.366%
Nanobac Pharmaceuticals, Incorporated -5.92 Million USD -27.404%
SQZ Biotechnologies Company -64.14 Million USD 88.223%
Evofem Biosciences, Inc. -17.37 Million USD 56.513%
Santhera Pharmaceuticals Holding AG 94.03 Million USD 108.033%
Mesoblast Limited -62.38 Million USD 87.893%
Propanc Biopharma, Inc. -1.53 Million USD -391.758%
Genus plc 73.7 Million USD 110.249%
VioQuest Pharmaceuticals, Inc. -6.61 Million USD -14.25%
CNBX Pharmaceuticals Inc. -3.54 Million USD -112.959%
Marizyme, Inc. -34.28 Million USD 77.966%
ContraFect Corporation -64.99 Million USD 88.379%
Nymox Pharmaceutical Corporation -8.77 Million USD 13.889%
PsyBio Therapeutics Corp. -4.52 Million USD -66.887%
Sienna Biopharmaceuticals, Inc. - USD Infinity%
RegeneRx Biopharmaceuticals, Inc. -1.4 Million USD -438.85%
Intellipharmaceutics International Inc. -2.64 Million USD -185.642%
AXIM Biotechnologies, Inc. -2.32 Million USD -225.053%
MultiCell Technologies, Inc. -518.04 Thousand USD -1358.103%
Accustem Sciences Inc. -3.74 Million USD -101.623%
RVL Pharmaceuticals plc -48.22 Million USD 84.337%
EV Biologics, Inc. -1.26 Million USD -496.121%
Q BioMed Inc. -617.62 Thousand USD -1123.009%
Emmaus Life Sciences, Inc. 3.57 Million USD 311.468%
Neon Bloom, Inc. -632.4 Thousand USD -1094.43%
Mosaic ImmunoEngineering Inc. -2.28 Million USD -230.649%
Biomind Labs Inc. -1.03 Million USD -630.139%
TetraLogic Pharmaceuticals Corporation - USD Infinity%
Pharming Group N.V. 9.87 Million USD 176.477%
Oncotelic Therapeutics, Inc. -7.16 Million USD -5.479%
Skye Bioscience, Inc. -13.54 Million USD 44.243%
Therapeutic Solutions International, Inc. -1.48 Million USD -407.838%
THC Farmaceuticals, Inc. -25 Thousand USD -30114.58%
Arch Therapeutics, Inc. -3.88 Million USD -94.465%
IMV Inc. -35.52 Million USD 78.736%
Acro Biomedical Co., Ltd. -15.86 Million USD 52.402%
Curative Biotechnology, Inc. -2.5 Million USD -201.909%
GB Sciences, Inc. -1.41 Million USD -431.99%
Alpha Cognition Inc. -9.7 Million USD 22.172%
HST Global, Inc. -5303.00 USD -142340.977%
CSL Limited 4.78 Billion USD 100.158%
Halberd Corporation -74.27 Thousand USD -10069.287%
Enzolytics Inc. -2.12 Million USD -255.963%
Resverlogix Corp. -11.74 Million USD 35.67%
Affymax, Inc. -14.29 Million USD 47.159%
SYBLEU INC -141.57 Thousand USD -5235.588%
Nuo Therapeutics, Inc. -3.06 Million USD -146.608%
argenx SE -216.02 Million USD 96.503%
MetaStat, Inc. - USD Infinity%
Northwest Biotherapeutics, Inc. -55.33 Million USD 86.35%
Enzon Pharmaceuticals, Inc. 1.21 Million USD 720.677%
Arno Therapeutics, Inc. - USD Infinity%
RespireRx Pharmaceuticals Inc. -1.49 Million USD -403.944%
GeneThera, Inc. - USD Infinity%
Inhibitor Therapeutics, Inc. 378.84 Thousand USD 2093.867%
AVAX Technologies, Inc. -6.11 Million USD -23.574%
Zenith Capital Corp. -8.6 Million USD 12.228%
Genscript Biotech Corporation -248.71 Million USD 96.963%
Ember Therapeutics, Inc. -17.42 Thousand USD -43259.423%
Anthera Pharmaceuticals, Inc. - USD Infinity%
Sigyn Therapeutics, Inc. -2.44 Million USD -208.758%
WPD Pharmaceuticals Inc. -176.02 Thousand USD -4191.25%
American Oriental Bioengineering, Inc. -39.63 Million USD 80.943%
Provectus Biopharmaceuticals, Inc. -2.89 Million USD -161.162%
Adynxx, Inc. - USD Infinity%
Helix BioMedix, Inc. -1.04 Million USD -621.93%
GlobeStar Therapeutics Corporation 6724.00 USD 112438.563%
VitaSpring Biomedical Co. Ltd. - USD Infinity%
Capstone Therapeutics Corp. -1.74 Million USD -331.637%
Cotinga Pharmaceuticals Inc. -1.92 Million USD -293.232%
ONE Bio Corp. 13.61 Million USD 155.488%
Reve Technologies, Inc. -181.08 Thousand USD -4071.257%
Burzynski Research Institute, Inc. - USD Infinity%
Wesana Health Holdings Inc. -2.05 Million USD -267.217%
Agentix Corp. -1.37 Million USD -450.655%
LadRx Corporation 412.28 Thousand USD 1932.15%
Cell Source, Inc. -4.27 Million USD -76.796%
ProtoKinetix, Incorporated -367.22 Thousand USD -1956.975%
Regen BioPharma, Inc. 1.46 Million USD 615.271%
Regen BioPharma, Inc. -936.94 Thousand USD -706.196%
NovAccess Global Inc. -1.03 Million USD -629.964%
Endonovo Therapeutics, Inc. 8.85 Million USD 185.315%
Itoco Inc. -1.86 Million USD -304.155%
Rasna Therapeutics, Inc. -379.62 Thousand USD -1889.791%
Pathfinder Cell Therapy, Inc. -1.11 Million USD -576.85%
Kadimastem Ltd -2.62 Million USD -187.826%
Oncology Pharma Inc. - USD Infinity%
Institute of Biomedical Research Corp. -239.15 Thousand USD -3058.539%
CytoDyn Inc. -18.02 Million USD 58.103%
Claritas Pharmaceuticals, Inc. - USD Infinity%
NDT Pharmaceuticals Inc. -79.02 Thousand USD -9458.067%
Mobile Lads Corp. -2.24 Million USD -237.042%
NanoSphere Health Sciences Inc. -12.22 Thousand USD -61668.297%
Qrons Inc. -40.08 Thousand USD -18745.949%
Alseres Pharmaceuticals, Inc. -485.67 Thousand USD -1455.278%
Advanced Proteome Therapeutics Corporation - USD Infinity%
Nascent Biotech, Inc. 527.43 Thousand USD 1532.153%
Rebus Holdings, Inc. -951 Thousand USD -694.284%
ImmunoCellular Therapeutics, Ltd. -1.06 Million USD -611.259%
International Stem Cell Corporation 202 Thousand USD 3839.428%
Bioxytran, Inc. -3.82 Million USD -97.732%
GlobeImmune, Inc. - USD Infinity%
Predictive Technology Group, Inc. - USD Infinity%
ProText Mobility, Inc. -52.64 Thousand USD -14249.63%
Cardax, Inc. - USD Infinity%
VG Life Sciences Inc. -2.46 Million USD -206.818%
Kaleido Biosciences, Inc. - USD Infinity%
Advaxis, Inc. -35.86 Million USD 78.941%
Adhera Therapeutics, Inc. - USD Infinity%
RenovaCare, Inc. - USD Infinity%
Regnum Corp. -45 Thousand USD -16685.878%
Innovation Pharmaceuticals Inc. -2.73 Million USD -175.882%
Neutra Corp. -181.24 Thousand USD -4067.597%
Windtree Therapeutics, Inc. -20.15 Million USD 62.53%
PureTech Health plc -11.62 Million USD 35.034%
Coeptis Therapeutics, Inc. -20.15 Million USD 62.527%
IXICO plc -707 Thousand USD -968.408%
IntelGenx Technologies Corp. -7.68 Million USD 1.709%
Gelesis Holdings, Inc. -48.34 Million USD 84.376%
CSL Limited 4.73 Billion USD 100.16%
Cellectis S.A. -92.63 Million USD 91.846%